BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
39 results:

  • 1. What have we learnt from the past - would treatment decisions for GEP-NET patients differ between 2012 to 2016 by the new recommendations in 2022?
    Stiefel R; Lehmann K; Winder T; Siebenhüner AR
    BMC Cancer; 2023 Feb; 23(1):148. PubMed ID: 36782152
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Real-world comparison of healthcare resource utilization and costs of [
    Cox T; O'Connell M; Leeuwenkamp O; Palimaka S; Reed N
    Curr Med Res Opin; 2022 Aug; 38(8):1305-1317. PubMed ID: 35418254
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Clinical value of miR-135 and miR-20a combined with multi-detector computed tomography in the diagnosis of gastric cancer.
    Han W; Bu X; Liu Y; Liu F; Ren Y; Cui Y; Kong S
    World J Surg Oncol; 2021 Sep; 19(1):283. PubMed ID: 34537058
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort.
    Lithgow K; Venkataraman H; Hughes S; Shah H; Kemp-Blake J; Vickrage S; Smith S; Humphries S; Elshafie M; Taniere P; Diaz-Cano S; Dasari BVM; Almond M; Ford S; Ayuk J; Shetty S; Shah T; Geh I
    Sci Rep; 2021 Sep; 11(1):17947. PubMed ID: 34504148
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical and phenotypical characteristics of submucosal invasive carcinoma in non-ampullary duodenal cancer.
    Matsueda K; Kanzaki H; Takenaka R; Nakagawa M; Matsueda K; Iwamuro M; Kawano S; Kawahara Y; Toji T; Tanaka T; Yagi T; Fujiwara T; Okada H
    PLoS One; 2021; 16(8):e0256797. PubMed ID: 34449813
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association between somatostatin analogues and diabetes mellitus in gastroenteropancreatic neuroendocrine tumor patients: A Surveillance, Epidemiology, and End Results-Medicare analysis of 5235 patients.
    Ni K; Yang JY; Baeg K; Leiter AC; Mhango G; Gallagher EJ; Wisnivesky JP; Kim MK
    Cancer Rep (Hoboken); 2021 Oct; 4(5):e1387. PubMed ID: 33835729
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [gastric adenocarcinoma with enteroblastic differentiation and elevated serum alpha fetoprotein].
    Li QZ; Zhao HB; Ban N; Wang Q; Zhang JJ; Ding SN; Li HH; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):886-890. PubMed ID: 32892552
    [No Abstract]    [Full Text] [Related]  

  • 8. Treatment Patterns and Health Resource Use Among Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated at a Tertiary Referral Center.
    Jalbert JJ; Casciano R; Meng J; Brais LK; Pulgar SJ; Berthon A; Dinet J; Kulke MH
    Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31999024
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.
    Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z
    Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Second jejunal loop adenocarcinoma associated with celiac disease: the first case report.
    Ursi P; Tarallo M; Crocetti D; Cavallaro G; Fiori E; D'Andrea V; De Toma G
    G Chir; 2019; 40(3):225-229. PubMed ID: 31484013
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Malignancies in Giant Cell Arteritis: A Population-based Cohort Study.
    Stamatis P; Turesson C; Willim M; Nilsson JÅ; Englund M; Mohammad AJ
    J Rheumatol; 2020 Mar; 47(3):400-406. PubMed ID: 31154410
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The contribution of second primary cancers to the mortality of patients with a gastric first primary cancer.
    Morais S; Antunes L; Bento MJ; Lunet N
    Eur J Gastroenterol Hepatol; 2019 Apr; 31(4):471-477. PubMed ID: 30601339
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
    Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
    Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of N- and O-linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer.
    Shu J; Yu H; Du H; Zhang J; Zhang K; Li X; Xie H; Li Z
    Cancer Biomark; 2018; 22(4):669-681. PubMed ID: 29865036
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of gastric cancer Patients.
    Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer.
    Liu F; Zhang S; Ren W; Yang T; Lv Y; Ling T; Zou X; Wang L
    Surg Endosc; 2018 May; 32(5):2575-2582. PubMed ID: 29264757
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Risk-Stratification Model Based on Lymph Node Metastasis After Noncurative Endoscopic Resection for Early gastric cancer.
    Jung DH; Huh CW; Kim JH; Hong JH; Park JC; Lee YC; Youn YH; Park H; Choi SH; Noh SH
    Ann Surg Oncol; 2017 Jun; 24(6):1643-1649. PubMed ID: 28150166
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Modest overall survival improvements from 1998 to 2009 in metastatic gastric cancer patients: a population-based SEER analysis.
    Ebinger SM; Warschkow R; Tarantino I; Schmied BM; Güller U; Schiesser M
    Gastric Cancer; 2016 Jul; 19(3):723-34. PubMed ID: 26391158
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data.
    Hess LM; Michael D; Mytelka DS; Beyrer J; Liepa AM; Nicol S
    Gastric Cancer; 2016 Apr; 19(2):607-615. PubMed ID: 25792290
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [State of health of populations residing in geothermal areas of Tuscany].
    Minichilli F; Nuvolone D; Bustaffa E; Cipriani F; Vigotti MA; Bianchi F
    Epidemiol Prev; 2012; 36(5 Suppl 1):1-104. PubMed ID: 23139155
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.